back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-16 17:59 Tx date 2026-05-28 |
$DRUG
Bright Minds Biosciences Inc. |
Vasilkevich, Alex
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$64,750
+35,000 vol $1.85 each |
61,750 | |
| Filed 2026-06-16 17:59 Tx date 2026-05-28 |
$DRUG
Bright Minds Biosciences Inc. |
Vasilkevich, Alex
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,250
+5,000 vol $1.65 each |
26,750 | |
| Filed 2026-06-16 17:58 Tx date 2026-05-28 |
$DRUG
Bright Minds Biosciences Inc. |
Vasilkevich, Alex
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$23,580
+4,500 vol $5.24 each |
21,750 | |
| Filed 2026-06-16 17:57 Tx date 2026-05-28 |
$DRUG
Bright Minds Biosciences Inc. |
Vasilkevich, Alex
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-64,750
-35,000 vol $1.85 each |
24,750 | |
| Filed 2026-06-16 17:57 Tx date 2026-05-28 |
$DRUG
Bright Minds Biosciences Inc. |
Vasilkevich, Alex
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,250
-5,000 vol $1.65 each |
59,750 | |
| Filed 2026-06-16 17:56 Tx date 2026-05-28 |
$DRUG
Bright Minds Biosciences Inc. |
Vasilkevich, Alex
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-23,580
-4,500 vol $5.24 each |
64,750 | |
| Filed 2026-06-15 12:49 Tx date 2026-05-25 |
$DRUG
Bright Minds Biosciences Inc. |
FARR, Stephen J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
55,000 | |
| Filed 2026-06-15 12:47 Tx date 2026-03-31 |
$DRUG
Bright Minds Biosciences Inc. |
FARR, Stephen J.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
35,000 | ||
| Filed 2026-06-15 12:39 Tx date 2025-02-26 |
$DRUG
Bright Minds Biosciences Inc. |
COLLINS, STEPHEN DOUGLAS
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2026-06-15 12:32 Tx date 2026-05-25 |
$DRUG
Bright Minds Biosciences Inc. |
COLLINS, STEPHEN DOUGLAS
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
130,000 | |
| Filed 2026-06-15 12:30 Tx date 2025-02-26 |
$DRUG
Bright Minds Biosciences Inc. |
COLLINS, STEPHEN DOUGLAS
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
||
| Filed 2026-06-15 12:22 Tx date 2025-02-10 |
$DRUG
Bright Minds Biosciences Inc. |
COLLINS, STEPHEN DOUGLAS
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-12 16:34 Tx date 2026-06-12 |
$DRUG
Bright Minds Biosciences Inc. |
McDonald, Ian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,256
+1,625 vol $61.08 each |
1,006,525 | |
| Filed 2026-06-11 17:48 Tx date 2026-06-01 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,200
+5,000 vol $1.84 each |
||
| Filed 2026-06-11 17:47 Tx date 2026-06-01 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,125
+2,500 vol $1.65 each |
||
| Filed 2026-06-10 14:11 Tx date 2026-06-01 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,200
+5,000 vol $1.84 each |
||
| Filed 2026-06-10 14:10 Tx date 2026-06-01 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,125
+2,500 vol $1.65 each |
||
| Filed 2026-06-10 14:11 Tx date 2026-06-01 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,200
+5,000 vol $1.84 each |
7,500 | |
| Filed 2026-06-10 14:10 Tx date 2026-06-01 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,125
+2,500 vol $1.65 each |
2,500 | |
| Filed 2026-06-09 17:30 Tx date 2026-06-03 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,125
+2,500 vol $1.65 each |
7,500 |